| dc.contributor.author | Kayadibi, Hüseyin | |
| dc.date.accessioned | 2019-05-10T09:39:54Z | |
| dc.date.available | 2019-05-10T09:39:54Z | |
| dc.date.issued | 2017 | |
| dc.identifier.citation | Kayadibi, H. (2017). Letter: changes in FIB-4 cut-off points for viral hepatitis. Alimentary Pharmacology and Therapeutics, 45(7), 1007-1008. | en_US |
| dc.identifier.issn | 0269-2813 | |
| dc.identifier.uri | https://doi.org/10.1111/apt.13956 | |
| dc.identifier.uri | https://hdl.handle.net/11491/802 | |
| dc.description.abstract | SIRS, I read with great interest the recently published article by Koh et al.,1 who proposed to improve the diagnostic accuracy of FIB-4 for advanced fibrosis in patients with chronic delta hepatitis by reducing the cut-off point from 3.25 to 2.03. I would like to share my thoughts and experience on the FIB-4 cut-off points for viral hepatitis. | en_US |
| dc.language.iso | eng | |
| dc.publisher | Blackwell Publishing Ltd | en_US |
| dc.relation.isversionof | 10.1111/apt.13956 | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | [Belirlenecek] | en_US |
| dc.title | Letter: changes in FIB-4 cut-off points for viral hepatitis | en_US |
| dc.type | other | en_US |
| dc.relation.journal | Alimentary Pharmacology and Therapeutics | en_US |
| dc.department | Hitit Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | en_US |
| dc.authorid | 0000-0002-3922-4517 | en_US |
| dc.identifier.volume | 45 | en_US |
| dc.identifier.issue | 7 | en_US |
| dc.identifier.startpage | 1007 | en_US |
| dc.identifier.endpage | 1008 | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
